CCM

Consonance Capital Management Portfolio holdings

AUM $7.28M
This Quarter Return
+104.41%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.67B
AUM Growth
+$1.67B
Cap. Flow
+$3.25M
Cap. Flow %
0.19%
Top 10 Hldgs %
58.94%
Holding
43
New
12
Increased
5
Reduced
11
Closed
11

Top Buys

1
MRSN icon
Mersana Therapeutics
MRSN
$138M
2
MGNX icon
MacroGenics
MGNX
$113M
3
GNMK
GenMark Diagnostics, Inc
GNMK
$101M
4
ATRA icon
Atara Biotherapeutics
ATRA
$76.3M
5
CGEN icon
Compugen
CGEN
$61.2M

Top Sells

1
UTHR icon
United Therapeutics
UTHR
$128M
2
SRPT icon
Sarepta Therapeutics
SRPT
$63.7M
3
EPZM
Epizyme, Inc
EPZM
$51.3M
4
QURE icon
uniQure
QURE
$44.3M
5
PRNB
Principia Biopharma Inc. Common Stock
PRNB
$41M

Sector Composition

1 Healthcare 85.4%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRSN icon
1
Mersana Therapeutics
MRSN
$35M
$138M 8.27%
+5,896,326
New +$138M
KPTI icon
2
Karyopharm Therapeutics
KPTI
$58.8M
$123M 7.37%
6,491,812
-688,888
-10% -$13M
MGNX icon
3
MacroGenics
MGNX
$110M
$113M 6.76%
+4,041,535
New +$113M
GNMK
4
DELISTED
GenMark Diagnostics, Inc
GNMK
$101M 6.08%
+6,894,481
New +$101M
CCXI
5
DELISTED
ChemoCentryx, Inc.
CCXI
$98.2M 5.88%
1,706,426
-591,353
-26% -$34M
AKBA icon
6
Akebia Therapeutics
AKBA
$825M
$95.5M 5.72%
7,031,283
-90,000
-1% -$1.22M
KDMN
7
DELISTED
Kadmon Holdings, Inc.
KDMN
$80.4M 4.82%
15,710,548
+101,600
+0.7% +$520K
CDNA icon
8
CareDx
CDNA
$737M
$79.1M 4.74%
2,232,612
-428,104
-16% -$15.2M
CYTK icon
9
Cytokinetics
CYTK
$5.94B
$78.9M 4.73%
3,347,232
-85,000
-2% -$2M
ATRA icon
10
Atara Biotherapeutics
ATRA
$86.7M
$76.3M 4.57%
+5,238,218
New +$76.3M
AUPH icon
11
Aurinia Pharmaceuticals
AUPH
$1.54B
$75.1M 4.5%
4,621,325
-2,288,049
-33% -$37.2M
ASMB icon
12
Assembly Biosciences
ASMB
$185M
$74.1M 4.44%
3,175,535
– –
KNSA icon
13
Kiniksa Pharmaceuticals
KNSA
$2.54B
$72.4M 4.34%
2,843,384
+602,605
+27% +$15.4M
SRPT icon
14
Sarepta Therapeutics
SRPT
$1.77B
$68.3M 4.09%
425,716
-397,449
-48% -$63.7M
OMER icon
15
Omeros
OMER
$292M
$61.4M 3.68%
4,169,872
-310,000
-7% -$4.56M
CGEN icon
16
Compugen
CGEN
$134M
$61.2M 3.67%
+4,077,421
New +$61.2M
APRE icon
17
Aprea Therapeutics
APRE
$9.15M
$48.6M 2.91%
+1,252,185
New +$48.6M
APTO
18
DELISTED
Aptose Biosciences, Inc.
APTO
$44M 2.64%
6,969,904
+1,173,422
+20% +$7.4M
LMNL
19
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$35.4M 2.12%
3,287,311
– –
ISEE
20
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$23.7M 1.42%
4,650,565
+1,500,000
+48% +$7.65M
BLU
21
DELISTED
BELLUS Health Inc.
BLU
$19.8M 1.19%
1,922,503
+325,000
+20% +$3.34M
OVID icon
22
Ovid Therapeutics
OVID
$87.5M
$18.9M 1.14%
2,570,878
-10,000
-0.4% -$73.7K
STXS icon
23
Stereotaxis
STXS
$246M
$16.3M 0.98%
+3,658,537
New +$16.3M
HARP
24
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$14M 0.84%
+844,162
New +$14M
ATNM icon
25
Actinium Pharmaceuticals
ATNM
$54M
$13M 0.78%
+37,000,000
New +$13M
1
2